Cavallin-Ståhl E - Search Results

1

Emotional disorders in testicular cancer survivors in relation to hypogonadism, androgen receptor polymorphism and treatment modality.

Eberhard J, Ståhl O, Cohn-Cedermark G, Cavallin-Ståhl E, Giwercman Y, Rastkhani H, Rylander L, Eberhard-Gran M, Kvist U, Giwercman A. Eberhard J, et al. J Affect Disord. 2010 May;122(3):260-6. doi: 10.1016/j.jad.2009.06.035. Epub 2009 Aug 4. J Affect Disord. 2010. PMID: 19656574

2

Androgen receptor gene CAG and GGN repeat lengths as predictors of recovery of spermatogenesis following testicular germ cell cancer treatment.

Bogefors K, Giwercman YL, Eberhard J, Stahl O, Cavallin-Stahl E, Cohn-Cedermark G, Arver S, Giwercman A. Bogefors K, et al. Among authors: cavallin stahl e. Asian J Androl. 2017 Sep-Oct;19(5):538-542. doi: 10.4103/1008-682X.191126. Asian J Androl. 2017. PMID: 27873769 Free PMC article.

3

Linkage between androgen receptor gene CAG trinucleotide repeat length and testicular germ cell cancer histological type and clinical stage.

Giwercman A, Lundin KB, Eberhard J, Ståhl O, Cwikiel M, Cavallin-Ståhl E, Giwercman YL. Giwercman A, et al. Eur J Cancer. 2004 Sep;40(14):2152-8. doi: 10.1016/j.ejca.2004.06.004. Eur J Cancer. 2004. PMID: 15341991

4

Risk factors for post-treatment hypogonadism in testicular cancer patients.

Eberhard J, Ståhl O, Cwikiel M, Cavallin-Ståhl E, Giwercman Y, Salmonson EC, Giwercman A. Eberhard J, et al. Eur J Endocrinol. 2008 Apr;158(4):561-70. doi: 10.1530/EJE-07-0684. Eur J Endocrinol. 2008. PMID: 18362304

5

Sexual function in men treated for testicular cancer.

Eberhard J, Ståhl O, Cohn-Cedermark G, Cavallin-Ståhl E, Giwercman Y, Rylander L, Eberhard-Gran M, Kvist U, Fugl-Meyer KS, Giwercman A. Eberhard J, et al. J Sex Med. 2009 Jul;6(7):1979-89. doi: 10.1111/j.1743-6109.2009.01298.x. Epub 2009 Apr 28. J Sex Med. 2009. PMID: 19453896

6

Hypogonadism risk in men treated for childhood cancer.

Romerius P, Ståhl O, Moëll C, Relander T, Cavallin-Ståhl E, Wiebe T, Giwercman YL, Giwercman A. Romerius P, et al. J Clin Endocrinol Metab. 2009 Nov;94(11):4180-6. doi: 10.1210/jc.2009-0337. Epub 2009 Sep 29. J Clin Endocrinol Metab. 2009. PMID: 19789207

7

Impact of therapy and androgen receptor polymorphism on sperm concentration in men treated for testicular germ cell cancer: a longitudinal study.

Eberhard J, Ståhl O, Giwercman Y, Cwikiel M, Cavallin-Ståhl E, Lundin KB, Flodgren P, Giwercman A. Eberhard J, et al. Hum Reprod. 2004 Jun;19(6):1418-25. doi: 10.1093/humrep/deh231. Epub 2004 Apr 22. Hum Reprod. 2004. PMID: 15105386

8

The impact of testicular carcinoma and its treatment on sperm DNA integrity.

Ståhl O, Eberhard J, Jepson K, Spano M, Cwikiel M, Cavallin-Ståhl E, Giwercman A. Ståhl O, et al. Cancer. 2004 Mar 15;100(6):1137-44. doi: 10.1002/cncr.20068. Cancer. 2004. PMID: 15022279 Free article.

9

Sperm DNA integrity in men treated for childhood cancer.

Romerius P, Ståhl O, Moëll C, Relander T, Cavallin-Ståhl E, Gustafsson H, Löfvander Thapper K, Jepson K, Spanò M, Wiebe T, Lundberg Giwercman Y, Giwercman A. Romerius P, et al. Clin Cancer Res. 2010 Aug 1;16(15):3843-50. doi: 10.1158/1078-0432.CCR-10-0140. Epub 2010 Jun 2. Clin Cancer Res. 2010. PMID: 20519359 Free article.

10

Estrogen receptor α single nucleotide polymorphism modifies the risk of azoospermia in childhood cancer survivors.

Romerius P, Giwercman A, Moëll C, Relander T, Cavallin-Ståhl E, Wiebe T, Halldén C, Giwercman YL. Romerius P, et al. Pharmacogenet Genomics. 2011 May;21(5):263-9. doi: 10.1097/FPC.0b013e328343a132. Pharmacogenet Genomics. 2011. PMID: 21430602

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

115 results

Search Page